D
Alamar Biosciences, Inc. ALMR
$29.16 -$0.79-2.64% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2026 06/30/2025
Total Cash And Short-Term Investments 287.16% --
Total Receivables 4.20% --
Inventory 13.72% --
Prepaid Expenses -10.64% --
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets -- --
Total Current Assets 134.24% --

Total Current Assets 134.24% --
Net Property, Plant & Equipment 36.00% --
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles -12.58% --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets 26.19% --
Total Assets 109.69% --

Total Accounts Payable 144.72% --
Total Accrued Expenses -25.13% --
Short-term Debt -- --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current 42.40% --
Total Finance Division Other Current Liabilities -38.55% --
Total Other Current Liabilities -38.55% --
Total Current Liabilities 16.27% --

Total Current Liabilities 16.27% --
Long-Term Debt -86.73% --
Short-term Debt -- --
Capital Leases 35.21% --
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities -32.66% --
Total Liabilities -39.69% --

Common Stock & APIC 4,163.73% --
Retained Earnings -6.94% --
Treasury Stock & Other -73.75% --
Total Common Equity 275.69% --

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible -- --
Preferred Stock, Others -- --
Total Preferred Equity -- --

Total Common Equity 275.69% --
Total Preferred Equity -- --
Total Minority Interest -- --
Total Equity 449.60% --